General Information
Revision date
2021-03-14
Product name
Citalopram Hydrobromide
CAS No.
59729-32-7
REACH No
is
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+(44)-870-8200418 (CHEMTREC (GB
Icons in SDS
Company Information
company name
Merck KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H336, H361d, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute toxicity, Oral (Category 4), H302 Reproductive toxicity (Category 2), H361d Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336 Long-term (chronic) aquatic hazard (Category 3), H412 For the full text of the H-Statements mentioned in this Section, see Section 16.
2.2 Label elements
Labelling according Regulation (EC) No 1272/2008
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H336 May cause drowsiness or dizziness. H361d Suspected of damaging the unborn child. H412 Harmful to aquatic life with long lasting effects. Reduced Labeling (<= 125 ml) H412 Harmful to aquatic life with long lasting effects. H361d Suspected of damaging the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P273 Avoid release to the environment. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.